Troponin may become the "gold-standard" heart attack diagnostic tool
This article was originally published in Clinica
Executive Summary
The cardiac marker troponin could soon replace creatine kinase-MB (CK-MB) as the new "gold standard" biochemical test for diagnosing heart attack in the US. By improving a doctor's ability to evaluate patients who come to emergency rooms with chest pain, serial tests for troponin could help reduce deaths and cut down on costs associated with malpractice suits and unnecessary hospital admissions.